NCT04452708View on ClinicalTrials.gov

HFNC and NIV for COVID-19 Complicated by Respiratory Failure

CompletedOBSERVATIONAL
Enrollment

26

Participants

Timeline

Start Date

June 11, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

April 30, 2022

Conditions
Respiratory Failure
Interventions
DEVICE

HFNC

HFNV vs NIV vs conventional nasal cannula

Trial Locations (1)

Unknown

Prince of Wales Hospital, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

collaborator

Health and Medical Research Fund

OTHER_GOV

NCT04452708 - HFNC and NIV for COVID-19 Complicated by Respiratory Failure | Biotech Hunter | Biotech Hunter